BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18537574)

  • 1. The challenges of dealing with promiscuous drug-metabolizing enzymes, receptors and transporters.
    Ma Q; Lu AY
    Curr Drug Metab; 2008 Jun; 9(5):374-83. PubMed ID: 18537574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters.
    Atkins WM
    FEBS J; 2020 Apr; 287(7):1306-1322. PubMed ID: 31663687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.
    Köhle C; Bock KW
    Biochem Pharmacol; 2009 Feb; 77(4):689-99. PubMed ID: 18606396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.
    Lamba J; Lamba V; Schuetz E
    Curr Drug Metab; 2005 Aug; 6(4):369-83. PubMed ID: 16101575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics: translating functional genomics into rational therapeutics.
    Evans WE; Relling MV
    Science; 1999 Oct; 286(5439):487-91. PubMed ID: 10521338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings.
    Lu L; Shi J; Li Q; Peng X; Dong L; Li Y; Dai P; Wang Y; Guo E; Zhou F; Liu Z
    Curr Med Chem; 2014; 21(22):2522-41. PubMed ID: 24358976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
    Wang H; LeCluyse EL
    Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenobiotic-activated receptors: from transcription to drug metabolism to disease.
    Ma Q
    Chem Res Toxicol; 2008 Sep; 21(9):1651-71. PubMed ID: 18707139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies.
    Poso A; Honkakoski P
    Mini Rev Med Chem; 2006 Aug; 6(8):937-47. PubMed ID: 16918499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers.
    Anwar-Mohamed A; Degenhardt OS; El Gendy MA; Seubert JM; Kleeberger SR; El-Kadi AO
    Toxicol In Vitro; 2011 Jun; 25(4):785-95. PubMed ID: 21281708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety.
    Lu AY
    Drug Metab Dispos; 1998 Dec; 26(12):1217-22. PubMed ID: 9860931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier.
    Pavek P; Smutny T
    Drug Metab Rev; 2014 Feb; 46(1):19-32. PubMed ID: 24020384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pregnane X receptor (PXR) prototype agonists on chemoprotective and drug metabolizing enzymes in mice.
    El-Sayed WM
    Eur J Pharmacol; 2011 Jun; 660(2-3):291-7. PubMed ID: 21496454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract.
    Drozdzik M; Oswald S
    Curr Med Chem; 2016; 23(39):4468-4489. PubMed ID: 27781942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.
    Mo SL; Liu YH; Duan W; Wei MQ; Kanwar JR; Zhou SF
    Curr Drug Metab; 2009 Sep; 10(7):730-53. PubMed ID: 19702527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes.
    Moscovitz JE; Kalgutkar AS; Nulick K; Johnson N; Lin Z; Goosen TC; Weng Y
    J Pharmacol Exp Ther; 2018 May; 365(2):262-271. PubMed ID: 29440451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.